WENA anewmeds.com: Net earnings per share for the last 12 months

WENA (Anew Medical Inc.) - company brandmark

The young biotech management of Anew Medical, Inc. (WENA) focuses on neurodegeneration therapy in an effort to attract venture capital. Earnings per share over the last four quarters, with data sourced from GURU.Markets, demonstrates current viability, where the 0.00 indicator expresses the state of the metric. Scientific alliances with laboratories are developing gene therapy for ALS, opening access to a massive market lacking effective medications.

WENA anewmeds.com Net earnings per share for the last 12 months (06/25/2024 - 09/17/2024)

Financial and market metric breakdowns for Anew Medical (WENA)

- share price and expert price forecast:
Fundamental company analysis:Anew Medical Inc. (WENA)
Manufactured products of anewmeds.com

For Anew Medical, Inc. (WENA), the 12-month net income per share trend serves as an indicator of operational viability. This metric correlates the company's total profit with the total number of issued shares. This calculation allows an investor to assess the real return on each share without quarterly distortions. The current working capital deficit and the freeze on gene development make this indicator a critical marker of solvency. Negative values here signal a high risk of liquidation for the micro-cap biotech.

Competitor analysis

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|CERE: Earnings per share for the trailing year